Cytogenetic study of myelodysplastic syndrome from India

Indian Journal of Medical Research

Volumn 130, Issue 2, 2009, Pages 155-159

  Vundinti, Babu Rao ^a   Kerketta, Lily ^a   Jijina, Farah ^a   Ghosh, K ^a  

^a KEM HOSPITAL   (India)

Author keywords

Clonal chromosome abnormality; Cytogenesis; Myelodysplastic syndrome; Occupational exposure; Refractory anaemia

Indexed keywords

PESTICIDE;

ADULT; AGE; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; CHROMOSOME ABERRATION; CHROMOSOME BANDING PATTERN; CHRONIC MYELOMONOCYTIC LEUKEMIA; CYTOGENETICS; DISEASE COURSE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; INDIA; INFANT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MONOSOMY; MONOSOMY 5; MONOSOMY 7; MYELODYSPLASTIC SYNDROME; OCCUPATIONAL EXPOSURE; REFRACTORY ANEMIA; REFRACTORY ANEMIA WITH EXCESS BLASTS; REFRACTORY ANEMIA WITH EXCESS BLASTS IN TRANSFORMATION; REFRACTORY ANEMIA WITH RINGED SIDEROBLASTS; RISK FACTOR;

ADULT; AGE FACTORS; ANIMALS; CHROMOSOME ABERRATIONS; CYTOGENETICS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INDIA; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; OCCUPATIONAL EXPOSURE;

EID: 70349553669     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Sultan C. Proposals for the classification of the myelodysplastic syndrome. Br J Haematol 1952; 51: 189-99.
2. Germing U, Aul C, Niemeyer CM, Haas R, Bennett JM. Epidemiology classification and prognosis of adults and children with myelodysplastic syndromes. Ann Hematol 2008; 87: 691-9.
3. Jacobs RH, Cornbleet MA, Vardiman JW, Larson RA, Le Beau MM, Rowley JD. Prognostic implications of morphology and Karyotype in primary myelodysplastic syndromes. Blood 1986; 67: 1765-72.
4. Larripa I, Labal de Vinuesa M, Bengio R, Slavutsky I. Chromosome studies in human hematologic diseases: II. Myelodysplastic syndromes. Haematologica 1987; 72: 399-403.
5. Horrike S, Taniwaki M, Misawa S, Abe T. Chromosome abnormalities and karyotypic evolution 83 patients with myelodysplastic syndrome and predictive value for prognosis. Cancer 1988; 62: 1129-38.
6. Mansoor AM, Bharadwaj TP, Sethuraman S, Chandy M, Puspha V, Kamada N, et al. Analysis of karyotype, SCE and point mutation of RAS oncogene in Indian MDS patients. Cancer Genet Cytogenet 1993; 65: 12-20.
7. Kadam P, Dadabhoy K, Bhisey A, Athale U, Nair C, Nair R, et al. Chromosome investigations and clinical outcome in patients with myelodysplastic syndromes. Indian J Med Res 1995; 101: 163-9.
8. Yunis JJ, Lobell M, Arnesen MA, Oken MM, Mayer MG, Rydell RE, et al. Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemia. Br J Haematol 1988; 68: 189-94.
9. Recommendations for a morphologic, immunologic and cytogenetic (MIC) working classification of the primary and therapy-related myelodysplastic disorders: Report of the workshop held in Scottsdale, Arizona, USA on February 23-25, 1987.
10. Otney HJ, Le Beau MM. The cytogenetics of myelodysplastic syndromes. Best Pract Res Clin Haematol 2001; 14: 479-95.
11. Levine EG, Bloomfield CD. Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure. Semin Oncol 1992; 19: 47-84.
12. Vogel VG, Fisher RE. Epidemiology and etiology of leukemia. Curr Opin Oncol 1993; 5: 26-34.
13. Nisse C, Haguenoer JM, Grandbastien B, Preudhomme C, Fontaine B, Brillet JM, et al. Occupational and environmental risk factors of the myelodysplastic syndromes in the North of France. Br J Haematol 2001; 11: 927-35.
14. Moorhead PS, Nowell PC, Mellman WJ, Battips DM, Hungerford DA. Exp Cell Res 1960; 20: 613-6.
15. Seabright M. A rapid banding technique for human chromosomes. Lancet 1971; 2: 971-2.
16. ISCN 2005. An International system for Human cytogenetic nomenclature. In: Shaffer LG,Tommorup N, editors. Basel: Karger; 2005.
17. Pinkel D, Straumet T, Gray JW. Cytogenetic analysis using quantitative, high sensitivity, fluorescence hybridization. Proc Natl Acad Sci USA 1986; 83: 2934-8.
18. Greenberg PL. The smoldering myeloid leukemic states: clinical and biologic features. Blood 1983; 61: 1035-44.
19. Williamson PJ, Kruger AR, Reynolds PJ, Hamblin TJ, Oscier DG. Establishing the incidence of myelodysplastic syndrome. Br J Haematol 1994; 87: 743-5.
20. Aul C, Gattermann N, Schneider W. Age-related incidence and other epidemiological aspects of myelodysplastic syndromes. Br J Haematol 1992; 82: 358-67.
21. Paydas S, Kocak R. Younger age observation in myelodysplastic syndrome. Leuk Res 1996; 20: 367.
22. Chen L, Li J, Zhu Y, Qiu H, Pan J, Wang R, et al. Conventional and molecular cytogenetic features of myelodysplastic syndrome in China. Exp Oncol 2007; 29: 299-303.
23. Haase D. Cytogenetic features in myelodysplastic syndromes. Ann Hematol 2008; 87: 515-26.
24. Farrow A, Jacobs A, West RR. Myelodysplasia, chemical exposure, and other environmental factors. Leukemia 1989; 3: 33-5.
25. Goldberg H, Lusk E, Moore J, Nowell PC, Besa EC. Survey of exposure to genotoxic agents in primary myelodysplastic syndrome - correlation with chromosome patterns and data on patients without hematological disease. Cancer Res 1990; 50: 6876-81.
26. Ido M, Nagata C, Kawakami N, Shimizu H, Yoshida Y, Nomura T, et al. A case-control study of myelodysplastic syndromes among Japanese men and women. Leuk Res 1996; 20: 727-31.
27. West RR, Stafford AD, White AD, Bowen DT, Padua RA. Cytogenetic abnormalities in the myelodysplastic syndromes and occupational or environmental exposure. Blood 2000; 95: 2093-97.
28. Rigolin GM, Cuneo A, Roberti MG, Bardi A, Bigoni R, Piva N, et al. Exposure to myelotoxic agents and myelodysplasia: case control study and correlation with clinicobiological findings. Br J Haematol 1998; 103: 189-197.
29. Lensch MW, Tischkowitz M, Christianson TA, Reifsteck CA, Speckhart SA, Jacobs PM, et al. Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukemia. Blood 2003; 102: 7-16.
30. Korgaonkar S, Babu VR, Kerketta L, Ghosh K. Chromosomal breakage in myelodysplastic syndrome. Asian Pac J Cancer Prev 2008; 9: 151-4.